Margules D L, Flynn J J, Walker J, Cooper C W
Brain Res Bull. 1979 Sep-Oct;4(5):589-91. doi: 10.1016/0361-9230(79)90098-4.
This paper contains the first demonstration of quantitative changes in the levels of calcitonin-like immunoreactivity in the pituitary. The concentration of calcitonin-like material in lean Zucker rats (?/+) was 0.42 +/- 0.09 ng/mg wet weight of pituitary. The pituitaries of obese rats (fa/fa) contained significantly greater levels (1.56 +/- 0.56 ng/mg wet weight). This 271% increase represents the first indication that pituitary calcitonin-like material may have a physiological role in genetically obese rats. Thyroidal calcitonin also elevated in the obese (111%). These large elevations in the calcitonin content of the glands of obese rats were not accompanied by significant elevations of calcitonin in the blood. This suggests that obese rats have problems with mechanisms for the release of calcitonin into the blood and might not be able to combat hypercalcemia as effectively as leans. However, this hypothesis remains to be tested.
本文首次证明了垂体中降钙素样免疫反应水平的定量变化。瘦型 Zucker 大鼠(?/+)垂体中降钙素样物质的浓度为 0.42±0.09 ng/mg 垂体湿重。肥胖大鼠(fa/fa)的垂体中该物质水平显著更高(1.56±0.56 ng/mg 湿重)。这 271%的升高首次表明垂体降钙素样物质可能在遗传性肥胖大鼠中具有生理作用。肥胖大鼠甲状腺降钙素也升高(111%)。肥胖大鼠腺体中降钙素含量的大幅升高并未伴随血液中降钙素的显著升高。这表明肥胖大鼠在将降钙素释放到血液中的机制方面存在问题,可能无法像瘦型大鼠那样有效地对抗高钙血症。然而,这一假设仍有待验证。